Allergan to invest Rs.20 crore in Global Bulk Drugs and Fine ChemicalsIllustrative image – not actual.

ALLERGAN India (AIL), the joint venture between the US-based Allergan Inc and Nicholas Piramal India, has plans to invest up to Rs 20 crore in Global Bulk Drugs and Fine Chemicals to set up a manufacturing facility in areas of ophthalmic and skin healthcare for AIL.

Global Bulk Drugs and Fine Chemicals is Hyderabad-based bulk drugs manufacturer belonging to the Piramal group.

 

← All latest storiesBack to top →